Telix Pharmaceuticals Americas News and Activities
Presence
Headquarters: United States (USA)
Telix Pharmaceuticals is one of the...
Telix Pharmaceuticals is a company listed under the stock ticker TLX (AU).
Telix Pharmaceuticals has a direct presence in 3 countries.Telix Pharmaceuticals has 3 subsidiaries including Telix Pharmaceuticals Americas, Telix Pharmaceuticals APAC and Telix Pharmaceuticals EMEA.
Executives
View the org chart displaying its 5 main executives
Most searched biographies at Telix Pharmaceuticals Americas
- Kevin Richardson, Chief Executive Officer
- Michael Didocha, Chief Financial Officer
- Alessandro Mascioni, Director, Targeting Technology Research
Popular executive movements at Telix Pharmaceuticals
- Maria Rivas will join the company as Director on May 11, 2026 (posted on April 10 2026).
- William Jellison has joined the company as Director (posted on April 10 2026).
- David Gill will join the company as Non-Executive Director on Jun. 11, 2026 (posted on April 2 2026).
Create your alert
to follow the executive moves at Telix Pharmaceuticals Americas.
Pharmaceuticals
Telix Pharmaceuticals has 1,912 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Telix Pharmaceuticals Americas
Social media about Telix Pharmaceuticals Americas
- Telix Pharmaceuticals Americas on Wikipedia, Google News & Yahoo Finance
- Telix Pharmaceuticals Americas on LinkedIn, X (Twitter) & YouTube
